Neuronetics (Nasdaq:STIM) announced that it implemented improved internet connectivity capabilities across its NeuroStar platform. Malvern, Pennsylvania-based Neuronetics develops products aimed at improving the life of patients with neuro health disorders. Its latest updates to NeuroStar particularly improve connectivity for providers with restricted networks. NeuroStar, a non-drug, non-invasive treatment can improve the quality of life for […]
Abbott FreeStyle Libre reader warning affects more than 4 million devices
The FDA today issued a notice classifying a recall of Abbott (NYSE:ABT) FreeStyle Libre readers as Class I, the most serious kind. Earlier this week, Abbott initiated a voluntary medical device correction to emphasize instructions for FreeStyle Libre continuous glucose monitor (CGM) readers. The company said it received a limited number of global reports (0.0017%) from users […]
FDA approves diaphragm pacing system from Synapse Biomedical for patients on ventilators
Synapse Biomedical announced that the FDA granted premarket approval (PMA) to its NeuRx diaphragm pacing system (DPS). Oberlin, Ohio-based Synapse designed NeuRx DPS for patients with spinal cord injuries who rely on mechanical ventilation. These spinal cord injury patients can utilize this option when they prefer a more natural method of breathing. Rather than using […]
EvoEndo CEO to leave, replacement named
EvoEndo announced today announced a new CEO and COO along with the departure of previous CEO Heather Underwood. Denver-based EvoEndo, which develops transnasal endoscopy technology, named Jonathan Hartmann as president and CEO. It appointed Ryan Hartman to the COO position. Underwood intends to remain with the company through April to support the leadership transition. Underwood […]
HeartFlow closes $215M Series F funding round
HeartFlow announced today that it closed a $215 million Series F funding round led by Bain Capital Life Sciences. New investor Janus Henderson Investors also contributed to the round. Participating existing investors included Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. J.P. Morgan acted as the sole placement […]
FDA clears CardioSTAT continuous, ambulatory ECG monitoring tech from Icentia
Icentia announced today that it received FDA 510(k) clearance for its CardioSTAT continuous ECG monitoring system. CardioSTAT relies on a wire-free, single-use recorder. Quebec City, Canada-based Icentia called its technology the leading wearable cardiac monitoring solution in Canada. In 2018, it expanded to the UK. According to a news release, CardioSTAT has been prescribed to […]
Better Therapeutics announces $6.5M private placement
Better Therapeutics (Nasdaq:BTTX) today announced a private placement of nearly 7.9 million shares of its common stock. The San Francisco-based digital therapeutic developer priced the shares at $0.825 per share. That represents the closing price of Better Therapeutics’ common stock on April 5, 2023. The private placement totals gross proceeds of approximately $6.5 million. Better […]
Henry Schein acquires majority stake in Biotech Dental
Henry Schein (Nasdaq:HSIC) announced today that it completed the acquisition of a majority ownership stake in Biotech Dental. Salon-de-Provence, France-based Biotech Dental provides dental implants, clear aligners and digital dental software. Melville, New York-based Henry Schein announced its plans to acquire a majority stake on Dec. 16, 2022. Biotech Dental’s offerings include Nemotec, an integrated […]
Bioventus CEO Ken Reali steps down
Bioventus (Nasdaq:BVS) announced today that Ken Reali stepped down as the company’s CEO and as a member of its board. Durham, North Carolina-based Bioventus said its board initiated a comprehensive search process to identify a permanent CEO. Until it finds one, the board appointed Anthony Bihl as interim CEO, effective immediately. Bihl has more than […]
Senseonics announces equity grants to employees under inducement plan
Senseonics (NYSE:SENS) announced today that it made equity grants to new employees under its 2019 inducement plan. The Germantown, Maryland-based long-term continuous glucose monitor (CGM) maker made these grants in accordance with NYSE requirements. On April 4, 2023, Senseonics granted 13 new non-executive employees non-qualified stock options. These options enable the employees to purchase an aggregate […]
Kindeva Drug Delivery names new chief commercial officer
Kindeva Drug Delivery announced today that it appointed David Stevens as its global chief commercial officer (CCO). Stevens’ role includes spearheading the commercial, business development and R&D activities for Kindeva. He aims to ensure continued growth, expansion and innovation from the drug delivery device contract development and manufacturing organization (CDMO). Get the full story at […]